- Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 1976;12:685-713.
- Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-665.
- Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 1976;12:897-913.
- Sala A, Rossoni G, Berti F, Muller-Peddinghaus R, Folco G. Transcellular synthesis of Cys-LT: from isolated cells to complex organ system. Adv Exp Med Biol 1997;43355-98.
- Sala A, Buccellati C, Zarini S, Bolla M, Bonazzi A, Folco GC. The polymorphonuclear leukocyte: a cell tuned for transcellular biosynthesis of cys-leukotrienes. J Physiol Pharmacol 1997;48:665-673.
- Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Cir Res 1981;49:1152-1163.
- Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Nat Acad Sci USA 1999;96:7220-7225.
- McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 [published erratum appears in Proc Natl Acad Sci USA 1999 May 11;96(10):5890]. Proc Nat Acad Sci USA 1999;96:272-277.
- McGiff JC, Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol 1999;277:R607-R623.
- Campbell WB, Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 1999;84:484-488.
- Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980,288:373-376.
- Furchgott RF. Research leading to nitric oxide: the importance of accidental findings. In Gryglewski RJ and Minuz P eds. Proceedings of 59th NATO ASI Course: Nitric Oxide-Basic Research and Clinical Application. Erice, September 7-17,2000.
- Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clini Investi 1986;78:l-5.
- Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
- Vergnani L, Hatrik S, Ricci F, Passaro A, Manzoli N, Zuliani G, Brovkovych V, Fellin R, Malinski T. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and Superoxide production: key role of L-arginine availability. Circulation 2000;101:1261-1266.
- Abu-Soud HM, Wang J, Rousseau DL, Fukuto JM, Ignarro LJ, Stuehr DJ. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biolog Chem 1995;27022997-23006.
- Abu-Soud HM, Rousseau DL, Stuehr DJ. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J Biologi Chemi 1996;271:32515-32518.
- Gryglewski RJ, Moncada S, Palmer RM. 1986. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol 1986;87:685-694.
- Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclo-oxygenase : interactions between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-1342.
- Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995;114:1171-1178.
- Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clini Investi 1996;97:2562-2568.
- Salvemini D.; Regulation o cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 1997;53:576-582.
- 22a. Gryglewski RJ, Chlopicki S, Uracz W, Marcinkiewicz E. Significance of endothelial prostocyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit 2001;7:1-16.
- Ziemianin B, Olszanecki R, Uracz W, Marcinkiewicz E, Gryglewski RJ. Thienopyridines: effects on cultured endothelial cells. J Physiol Pharmacol 1999;50:597-604.
- Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biolog Chem 1985;260:3440-3450.
- Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992;358:676-678.
- Jia L, Furchgott RF. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 1993;267:371-378.
- Jaffe EA, Armellino D, Lam G, Cordon-Cardo C, Murray HW, Evans RL. IFNgamma and IFN-alpha induce the expression and synthesis of Leu-13 antigen by cultured human endothelial cells. J Immunol 1989;143:3961-3966.
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
- Gryglewski RJ, Korbut R, Ocetkiewicz A, Stachura J. In vivo method for quantitation for anti-platelet potency of drugs. Naunyn-Schmiedebergs Arch Pharmacol 1978;302:25-30.
- Gryglewski RJ, Korbut R, Swies J., Uracz W. Effect of ticlopidine on streptokinaseinduced thrombolysis in rats. Wiener Klinische Wochenschrift 1999;111:98-102.
- Gryglewski RJ, Uracz W, Swies J. Unusual effects of aspirin on ticlopidine induced thrombolysis. Thorax 2000;50 suppl 2:S17-S19.
- Mackiewicz ZGRJ, Swies J, Dabros W, Uracz W Streptokinase-induced changes in the structure of platelets. Ex vivo study. Acta Med Lituanica 1996;2:3-8.
- Chlopicki S, Bartus JB, Gryglewski RJ. Biphasic response to lipopolysaccharide from E-coli in the isolated-ventilated blood-perfused rat lung. J Physiol Pharmacol 1999;50:551-565.
- Uhlig S, Heiny O. Measuring the weight of the isolated perfused rat lung during negative pressure ventilation. J Pharmacol Toxi Meth 1995;33:147-152.
- Mugge A, Peterson T, Harrison DG. Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists. Circulation 1991;83:1404-1409.
- Ferreira SH. A bradykinin-potentiating factor (BPF) present in the venom of Bothropsjaracca. Br J Pharmacol 1965;24:163-169.
- Bakhle YS, Reynard AM, Vane JR. Metabolism of the angiotensins in isolated perfused tissues. Nature 1969;222:956-959.
- Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [see comments] [published errata appear in N Eng J Med 2000 Mar 9;342 (10):748 and 2000 May 4;342 (180:1376]. N Engl J med 2000;342:145-153.
- Wagener FA, da Silva JL, Parley T, de Witte T, Kappas A, Abraham NG. Differential effects of heme oxygenas e isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 1999;291:416-423.
- Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenas e product, presumably carbon-monoxide, mediates a vasodepressor function in rats. Hypertension 1995;25:166-169.
- Yamasaki S, Sawada S, Komatsu S, Kawahara T, Tsuda Y, Sato T, Toratani A, Kono Y, Higaki T, Imamura H, Tada Y, Akamatsu N, Tamagaki T, Tsuji H, Nakagawa M. Effects of bradykinin on prostaglandin 1(2) synthesis in human vascular endothelial cells. Hypertension 2000;36:201-207.
- Gryglewski RJ, Wolkow PP, Uracz W, Janowska E, Bartus JB, Balbatun O, Patton S, Brovkovych V, Malinski T. Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats. Circulation Research 1998;82:819-827.
- Kanwar S, Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz. 1995;3:93-104.
- Provost P, Merhi Y. Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions. Thromb Res 1997;85:315-326.
- Vane JR. The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation. Philos Trans R Soc Lond B Biol Sci 1994;343:225-246.
- Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 1993;344:251-264.
- Kuehl FA, Jr., Humes JL, Egan RW, Ham EA, Beveridge GC, Van Arman CG. Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature 1977;265:170-173.
Pediatric Pathology & Molecular Medicine
Volume 21, 2002 - Issue 3